
|Articles|July 1, 2002
- Volume 0 0
Tell Your Patients with Diabetes About Aspirin
Advertisement
Patients with diabetes can prevent cardiovascular disease with aspirin therapy, said researchers in a recent issue of Diabetes Care. In January 2000, the American Diabetes Association recommended aspirin therapy for everyone over the age of 30 with diabetes and no known contraindications to such therapy. Although the new study showed that a substantial portion of those with diabetes in a single health care system had been counseled about aspirin use, 29% had not received information and 34% were not taking daily aspirin.
Articles in this issue
almost 24 years ago
Olmesartan Medoxomil (CS-866) (Benicar)almost 24 years ago
Duration of Breast-Feeding Linked to IQ in Adulthoodalmost 24 years ago
Sinus Headachealmost 24 years ago
Got RA? Don't Delay!almost 24 years ago
Find the Blood Pressure Health Stations Nearest Youalmost 24 years ago
Quitting Smoling After Age 65 Adds Years To Lifealmost 24 years ago
Crab Shells and Cow Cartilagealmost 24 years ago
Shocking the Immune System to Fight Rheumatoid Arthritisalmost 24 years ago
Take Blook Pressure in Both Armsalmost 24 years ago
Fat-Free Doesn't Mean Calorie-Free!Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Factors Associated With GLP-1 RA Nonresponse in T2D—and What Pharmacists Should Screen For
2
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
3
ADA 2026: Survodutide Cuts Visceral Fat and Normalizes Liver Fat in MASLD. Here's What the Data Mean for Metabolic Risk
4
The Hidden Reimbursement Crisis in Medicare’s Drug Price Negotiation Program
5





































































































































